starting human trials on a COVID-19 vaccine candidate from a Calgary company — but some think it’s too little, too late.Sixty people are taking part in the trial for the vaccine developed by Calgary-based Providence Therapeutics.
Calgary company begins human clinical trials for its COVID-19 vaccine candidate The first results are expected next month, and if they are promising, the Phase 2 trial could follow in May.While Canada does not currently have the capacity to produce the millions of doses needed, Providence Therapeutics has partnered with another Calgary company, Northern RNA Inc., to build manufacturing infrastructure.While that won’t help the current vaccine shortage, it could help down the road.Providence Therapeutics CEO Brad.